ARM

Arm Holdings plc American Depositary Shares

67
Fundamentals66/ 100
Valuation56/ 100
Upside potential74/ 100
Risk potential28/ 100

ARM has the edge over CRWV overall, supported by stronger fundamentals and lower modeled downside.

CRWV

CoreWeave, Inc. Class A Common Stock

52
Fundamentals43/ 100
Valuation50/ 100
Upside potential65/ 100
Risk potential42/ 100

CRWV's outlook is improving, though it still trails on the overall score.

ARM Fundamentals

MetricStatus
Healthy
Healthy
Strong
Strong

ARM's revenue, profitability, cash flow and balance sheet are all currently healthy.

CRWV Fundamentals

MetricStatus
Strong
Under pressure
Weak
Strong

CRWV's revenue and balance sheet are currently strong, but its profitability and cash flow are under pressure.

ARM PE Valuation

CHEAPFAIREXPENSIVE160x321x481x642x
CHEAPFAIREXPENSIVE160x321x481x642x
LevelPEPriceVs current
Cheap167x$147-27%
Fair224x$197-1.4%
Current227x$200—
Expensive361x$317+59%

Historical ranges are pointers, not guarantees.

ARM's PE is in its fair range at 227x.

CRWV PE Valuation

CRWV has no meaningful PE right now: it lost money over the past year.

ARM Forward outlook

MetricOutlook
--
Strong growth
Strong growth
Improving
Moderate
Moderate

Analysts expect strong earnings and revenue growth for ARM, with profitability improving.

CRWV Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
Strongly improving
Moderate
Low

Analysts expect CRWV's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

ARM Risk to reward

ScenarioChangePrice
Upside+80%$358.92
Downside-28%$143.85

Calculated from the latest close: $199.78 on Nov 12.

ARM has a better modeled risk to reward balance than CRWV, with more potential upside and less potential downside.

CRWV Risk to reward

ScenarioChangePrice
Upside+79%$101.48
Downside-42%$32.77

Calculated from the latest close: $56.60 on Nov 12.

CRWV trails ARM on modeled risk to reward, with less potential upside and more potential downside.

ARM Earnings Per Share

Q4 2023: $0.08Q1 2024: $0.29Q3 2024: $0.60Q4 2024: $0.76Q1 2025: $0.75Q2 2025: $0.66Q3 2025: $0.78Q4 2025: $0.75Q1 2026: $0.85Q2 2026: $0.98Q3 2026: $0.88
Q4 2023: $0.08Q1 2024: $0.29Q3 2024: $0.60Q4 2024: $0.76Q1 2025: $0.75Q2 2025: $0.66Q3 2025: $0.78Q4 2025: $0.75Q1 2026: $0.85Q2 2026: $0.98Q3 2026: $0.88
QuarterTTM EPSYoY
Q3 2026$0.88+13%
Q2 2026$0.98+48%
Q1 2026$0.85+13%
Q4 2025$0.75-1.3%
Q3 2025$0.78+30%
Q1 2025$0.75+159%
Q4 2024$0.76+850%
Q3 2024$0.60+233%

ARM has the edge over CRWV on earnings quality, reporting a profit while its opponent remains loss making.

CRWV Earnings Per Share

Q3 2024: $-2.42Q4 2024: $-2.17Q1 2025: $-3.34Q2 2025: $-3.10Q3 2025: $-2.48Q4 2025: $-2.81Q1 2026: $-2.72Q2 2026: $-3.26Q3 2026: $-4.31
Q3 2024: $-2.42Q4 2024: $-2.17Q1 2025: $-3.34Q2 2025: $-3.10Q3 2025: $-2.48Q4 2025: $-2.81Q1 2026: $-2.72Q2 2026: $-3.26Q3 2026: $-4.31
QuarterTTM EPSYoY
Q3 2026-$4.31-$1.83
Q2 2026-$3.26-$0.16
Q1 2026-$2.72+$0.62
Q4 2025-$2.81-$0.64
Q3 2025-$2.48-$0.06

CRWV lost $4.31 per share over the past year, a bigger loss than the year before.

ARM Quarterly Revenue

Q4 2023: $824MQ1 2024: $928MQ2 2024: $939MQ3 2024: $844MQ4 2024: $983MQ1 2025: $1.2BQ2 2025: $1.1BQ3 2025: $1.1BQ4 2025: $1.2BQ1 2026: $1.5BQ2 2026: $1.3BQ3 2026: $1.4B
Q4 2023: $824MQ1 2024: $928MQ2 2024: $939MQ3 2024: $844MQ4 2024: $983MQ1 2025: $1.2BQ2 2025: $1.1BQ3 2025: $1.1BQ4 2025: $1.2BQ1 2026: $1.5BQ2 2026: $1.3BQ3 2026: $1.4B
QuarterRevenueYoY
Q3 2026$1.4B+27%
Q2 2026$1.3B+22%
Q1 2026$1.5B+20%
Q4 2025$1.2B+26%
Q3 2025$1.1B+34%
Q2 2025$1.1B+12%
Q1 2025$1.2B+34%
Q4 2024$983M+19%

ARM's revenue has grown year over year for eight quarters in a row: $1.4B last quarter, up 27% from the same quarter a year ago.

CRWV Quarterly Revenue

Q4 2023: $116MQ1 2024: $189MQ2 2024: $395MQ3 2024: $584MQ4 2024: $747MQ1 2025: $982MQ2 2025: $1.2BQ3 2025: $1.4BQ4 2025: $1.6BQ1 2026: $2.1BQ2 2026: $2.6BQ3 2026: $3.7B
Q4 2023: $116MQ1 2024: $189MQ2 2024: $395MQ3 2024: $584MQ4 2024: $747MQ1 2025: $982MQ2 2025: $1.2BQ3 2025: $1.4BQ4 2025: $1.6BQ1 2026: $2.1BQ2 2026: $2.6BQ3 2026: $3.7B
QuarterRevenueYoY
Q3 2026$3.7B+168%
Q2 2026$2.6B+112%
Q1 2026$2.1B+112%
Q4 2025$1.6B+110%
Q3 2025$1.4B+134%
Q2 2025$1.2B+207%
Q1 2025$981.6M+420%
Q4 2024$747.4M+544%

CRWV has the edge over ARM on sales, with stronger typical year-over-year growth.

ARM Free Cash Flow

Q4 2023: $289MQ1 2024: $656MQ2 2024: −$319MQ3 2024: −$47MQ4 2024: $360MQ1 2025: $184MQ2 2025: $178MQ3 2025: $429MQ4 2025: $186MQ1 2026: $186MQ2 2026: $705MQ3 2026: $135M
Q4 2023: $289MQ1 2024: $656MQ2 2024: −$319MQ3 2024: −$47MQ4 2024: $360MQ1 2025: $184MQ2 2025: $178MQ3 2025: $429MQ4 2025: $186MQ1 2026: $186MQ2 2026: $705MQ3 2026: $135M
QuarterFree cash flowYoY
Q3 2026$135M-69%
Q2 2026$705M+296%
Q1 2026$186M+1.1%
Q4 2025$186M-48%
Q3 2025$429M+$476M
Q2 2025$178M+$497M
Q1 2025$184M-72%
Q4 2024$360M+25%

ARM has the edge over CRWV on cash generation, producing positive trailing cash flow while its opponent burns cash.

CRWV Free Cash Flow

Q4 2023: −$1.1BQ1 2024: $297MQ2 2024: −$2.4BQ3 2024: −$574MQ4 2024: −$3.3BQ1 2025: −$1.3BQ2 2025: −$2.7BQ3 2025: −$700MQ4 2025: −$2.5BQ1 2026: −$4.7BQ2 2026: −$5.7BQ3 2026: −$7.5B
Q4 2023: −$1.1BQ1 2024: $297MQ2 2024: −$2.4BQ3 2024: −$574MQ4 2024: −$3.3BQ1 2025: −$1.3BQ2 2025: −$2.7BQ3 2025: −$700MQ4 2025: −$2.5BQ1 2026: −$4.7BQ2 2026: −$5.7BQ3 2026: −$7.5B
QuarterFree cash flowYoY
Q3 2026-$7.5B-$6.8B
Q2 2026-$5.7B-$3B
Q1 2026-$4.7B-$3.4B
Q4 2025-$2.5B+$810.3M
Q3 2025-$699.8M-$125.8M
Q2 2025-$2.7B-$339.3M
Q1 2025-$1.3B-553%
Q4 2024-$3.3B-$2.2B

CRWV has burned cash in almost every quarter: −$20.4B over the past year, against −$8.1B the year before.

ARM Total Shares

Q4 2023: 1BQ1 2024: 1BQ2 2024: 1.1BQ3 2024: 1.1BQ4 2024: 1.1BQ1 2025: 1.1BQ2 2025: 1.1BQ3 2025: 1.1BQ4 2025: 1.1BQ1 2026: 1.1BQ2 2026: 1.1BQ3 2026: 1.1B
Q4 2023: 1BQ1 2024: 1BQ2 2024: 1.1BQ3 2024: 1.1BQ4 2024: 1.1BQ1 2025: 1.1BQ2 2025: 1.1BQ3 2025: 1.1BQ4 2025: 1.1BQ1 2026: 1.1BQ2 2026: 1.1BQ3 2026: 1.1B
PeriodChange %Net change
Quarterly+0.1%+1M shares
1 year+0.9%+10M shares
3 years+5.2%+53.7M shares

ARM has the edge over CRWV on shareholder dilution, with a more favorable share count trend.

CRWV Total Shares

Q4 2023: 404MQ1 2024: 404MQ2 2024: 404MQ3 2024: 214MQ4 2024: 239MQ1 2025: 249MQ2 2025: 487MQ3 2025: 498MQ4 2025: 436MQ1 2026: 527MQ2 2026: 551MQ3 2026: 559M
Q4 2023: 404MQ1 2024: 404MQ2 2024: 404MQ3 2024: 214MQ4 2024: 239MQ1 2025: 249MQ2 2025: 487MQ3 2025: 498MQ4 2025: 436MQ1 2026: 527MQ2 2026: 551MQ3 2026: 559M
PeriodChange %Net change
Quarterly+1.5%+8M shares
1 year+12%+61.1M shares

CRWV has 559M diluted shares, up 12% from a year ago.

ARM Net Leverage

QuarterNet LeverageStatus
Q1 2023-1.6xNet Cash

ARM has more cash than debt.

CRWV Net Leverage

Q4 2024: 19.3xQ1 2025: 8.4xQ2 2025: 6.5xQ3 2025: 5.6xQ4 2025: 7.6xQ1 2026: 7.6xQ2 2026: -1.5xQ3 2026: -0.8x
Q4 2024: 19.3xQ1 2025: 8.4xQ2 2025: 6.5xQ3 2025: 5.6xQ4 2025: 7.6xQ1 2026: 7.6xQ2 2026: -1.5xQ3 2026: -0.8x
QuarterNet LeverageStatus
Q3 2026-0.8xNet Cash
Q2 2026-1.5xNet Cash
Q1 20267.6xHigh
Q4 20257.6xHigh
Q3 20255.6xHigh
Q2 20256.5xHigh
Q1 20258.4xHigh
Q4 202419.3xHigh

CRWV has more cash than debt.

ARM Weekly Momentum

MetricValueStatus
RSI43.0Neutral
Stochastic11.0Oversold

ARM's weekly RSI is 43 (neutral) and its Stochastic is 11 (oversold).

CRWV Weekly Momentum

MetricValueStatus
RSI39.7Neutral
Stochastic11.3Oversold

CRWV's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).

ARM PE vs Technology Sector

MetricARMSector medianRelative
PE227x28x715% above
PE %512328 pts above

ARM is trading at 227x earnings, a 715% premium to the Technology sector's median of 28x.

CRWV PE vs Technology Sector

CRWV has no meaningful PE right now: it lost money over the past year.

ARM Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$237.816% below
20 week MA$257.322% below
50 week MA$213.96.6% below
100 week MA$176.513% above

ARM has stronger trend alignment. ARM is above 1 of 4 weekly averages versus CRWV above 0 of 3.

CRWV Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$66.615% below
20 week MA$77.427% below
50 week MA$87.435% below

CRWV is in a downtrend: it's below all three of its weekly moving averages, and 35% below its 50-week average.

ARM Yearly ROI

YearStart priceEnd priceROI
2023$60.8$75.2+24%
2024$75.2$129.2+72%
2025$129.2$110.3-15%
2026 YTD$110.3$199.8+81%

ARM has the edge over CRWV on returns for 2026, with the stronger performance.

CRWV Yearly ROI

YearStart priceEnd priceROI
2025$40.0$76.4+91%
2026 YTD$76.4$56.6-26%

CRWV has finished every year since 2025 higher, and it's down 26% so far in 2026.

Give your agent the market.

Get API key